Developing a cardiology-oncology clinical practice guideline
- PMID: 20728705
- DOI: 10.1016/j.pcad.2010.06.001
Developing a cardiology-oncology clinical practice guideline
Abstract
Clinical Practice Guidelines (CPG) have become an increasingly common method to assist practitioner and patient decisions about health care for specific medical problems. CPGs generally address a single medical diagnosis or syndrome leaving practitioners and patients with little guidance when two major medical diagnoses exist such as in the case of heart disease and cancer. As cancer and heart disease are both diseases of the elderly and share many common risk factors it is likely they will coexist in many patients. Thus screening for and preventing and treating heart disease in the cancer patient assumes increasing importance as aggressive cancer therapies are applied to older patients and as a growing number of cardiovascular side effects of anti-cancer therapy are described. Careful evaluation of heart disease in the cancer patient will likely improve quality of life but may also improve mortality as the presence or development of heart disease may significantly limit life-saving cancer therapies. The rationale, potential problems, and important steps in developing a cardiology-oncology guideline are discussed.
Copyright 2010. Published by Elsevier Inc.
Similar articles
-
The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):88-93. doi: 10.1016/j.pcad.2010.06.002. Prog Cardiovasc Dis. 2010. PMID: 20728695
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
Heart disease in cancer patients: a burgeoning field where optimizing patient care is requiring interdisciplinary collaborations.Heart Fail Clin. 2011 Jul;7(3):xxi-xxiii. doi: 10.1016/j.hfc.2011.04.001. Epub 2011 May 20. Heart Fail Clin. 2011. PMID: 21749881 No abstract available.
-
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.Eur J Heart Fail. 2011 Jan;13(1):1-10. doi: 10.1093/eurjhf/hfq213. Eur J Heart Fail. 2011. PMID: 21169385 Review.
-
Cardiac toxicity from systemic cancer therapy: a comprehensive review.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):94-104. doi: 10.1016/j.pcad.2010.05.006. Prog Cardiovasc Dis. 2010. PMID: 20728696 Review.
Cited by
-
Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy.Open Heart. 2014 Jul 18;1(1):e000116. doi: 10.1136/openhrt-2014-000116. eCollection 2014. Open Heart. 2014. PMID: 25332820 Free PMC article.
-
Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?J Cancer Surviv. 2013 Jun;7(2):253-61. doi: 10.1007/s11764-013-0267-9. Epub 2013 Feb 16. J Cancer Surviv. 2013. PMID: 23417882 Free PMC article.
-
Vivre avec un cancer et d’autres maladies chroniques : perceptions des patients au sujet de leur expérience des soins de santé.Can Oncol Nurs J. 2017 Feb 1;27(1):49-55. doi: 10.5737/236880762714955. eCollection 2017 Winter. Can Oncol Nurs J. 2017. PMID: 31148793 Free PMC article. French.
-
Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.J Natl Cancer Inst. 2014 Sep 10;106(9):dju232. doi: 10.1093/jnci/dju232. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25210198 Free PMC article.
-
Living with cancer and other chronic conditions: Patients' perceptions of their healthcare experience.Can Oncol Nurs J. 2017 Feb 1;27(1):43-48. doi: 10.5737/236880762714348. eCollection 2017 Winter. Can Oncol Nurs J. 2017. PMID: 31148776 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials